Skip to main content
TipRanks
Go Ultimate75% OFF

Mohammad Azab Insider Profile

53 Followers

Mohammad Azab, Director at Lisata Therapeutics, holds 104.92K shares in Lisata Therapeutics (Ticker: LSTA), holds 0.00 shares in Durect (Ticker: DRRX), holds 74.22K shares in Xenon (Ticker: XENE).

Mohammad Azab's Trading History

LSTA
Lisata Therapeutics
Jan 13, 2026DirectorUninformative Buy―$95.48K
DRRX
Durect
Sep 12, 2025―Uninformative Sell―$0.00
XENE
Xenon
Dec 20, 2023DirectorUninformative Buy42.55K$2.79M
~ASTX
Astex Pharmaceuticals
――――
NVLNF
Novelion Therapeutics
―――$842.40

You May Also Like

Mohammad Azab insider profile FAQ

What is the percentage of profitable transactions made by Mohammad Azab?
The percentage of profitable transactions made by Mohammad Azab is 63%.
What is the average return per transaction made by Mohammad Azab?
The average return per transaction made by Mohammad Azab is 118.50%.
What stocks does Mohammad Azab hold?
Mohammad Azab holds: LSTA, DRRX, XENE, NVLNF, ~ASTX stocks.
What was Mohammad Azab's most profitable transaction?
Mohammad Azab’s most profitable transaction was an Informative Buy of XENE stock on September 25, 2017. The return on the trade was 352.90%.
What is Mohammad Azab's role in Lisata Therapeutics?
Mohammad Azab's role in Lisata Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.